Legend Biotech Statistics
Total Valuation
Legend Biotech has a market cap or net worth of $7.51 billion. The enterprise value is $6.64 billion.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Legend Biotech has 183.45 million shares outstanding. The number of shares has increased by 6.16% in one year.
Current Share Class | n/a |
Shares Outstanding | 183.45M |
Shares Change (YoY) | +6.16% |
Shares Change (QoQ) | +0.37% |
Owned by Insiders (%) | 0.06% |
Owned by Institutions (%) | 50.93% |
Float | 80.93M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 14.36 |
Forward PS | 8.56 |
PB Ratio | 6.73 |
P/TBV Ratio | 6.74 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 12.77 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.31.
Current Ratio | 4.98 |
Quick Ratio | 4.86 |
Debt / Equity | 0.31 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -15.76 |
Financial Efficiency
Return on equity (ROE) is -28.35% and return on invested capital (ROIC) is -14.06%.
Return on Equity (ROE) | -28.35% |
Return on Assets (ROA) | -12.28% |
Return on Capital (ROIC) | -14.06% |
Revenue Per Employee | $284,876 |
Profits Per Employee | -$190,651 |
Employee Count | 1,826 |
Asset Turnover | 0.29 |
Inventory Turnover | 29.25 |
Taxes
In the past 12 months, Legend Biotech has paid $2.67 million in taxes.
Income Tax | 2.67M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.49% in the last 52 weeks. The beta is 0.11, so Legend Biotech's price volatility has been lower than the market average.
Beta (5Y) | 0.11 |
52-Week Price Change | -28.49% |
50-Day Moving Average | 44.92 |
200-Day Moving Average | 50.72 |
Relative Strength Index (RSI) | 45.44 |
Average Volume (20 Days) | 1,651,957 |
Short Selling Information
Short Interest | 15.86M |
Short Previous Month | 11.95M |
Short % of Shares Out | 16.37% |
Short % of Float | n/a |
Short Ratio (days to cover) | 12.18 |
Income Statement
In the last 12 months, Legend Biotech had revenue of $520.18 million and -$348.13 million in losses. Loss per share was -$1.92.
Revenue | 520.18M |
Gross Profit | -87.72M |
Operating Income | -351.24M |
Pretax Income | -287.07M |
Net Income | -348.13M |
EBITDA | -340.56M |
EBIT | -351.24M |
Loss Per Share | -$1.92 |
Full Income Statement Balance Sheet
The company has $1.21 billion in cash and $346.59 million in debt, giving a net cash position of $865.81 million or $4.72 per share.
Cash & Cash Equivalents | 1.21B |
Total Debt | 346.59M |
Net Cash | 865.81M |
Net Cash Per Share | $4.72 |
Equity (Book Value) | 1.12B |
Book Value Per Share | 6.08 |
Working Capital | 1.08B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$157.60 million and capital expenditures -$16.07 million, giving a free cash flow of -$173.67 million.
Operating Cash Flow | -157.60M |
Capital Expenditures | -16.07M |
Free Cash Flow | -173.67M |
FCF Per Share | -$0.95 |
Full Cash Flow Statement Margins
Gross margin is -16.86%, with operating and profit margins of -67.52% and -66.92%.
Gross Margin | -16.86% |
Operating Margin | -67.52% |
Pretax Margin | -66.41% |
Profit Margin | -66.92% |
EBITDA Margin | -65.47% |
EBIT Margin | -67.52% |
FCF Margin | -46.21% |
Dividends & Yields
Legend Biotech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.16% |
Shareholder Yield | -6.16% |
Earnings Yield | -4.64% |
FCF Yield | -2.31% |
Dividend Details Analyst Forecast
The average price target for Legend Biotech is $81.46, which is 98.97% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $81.46 |
Price Target Difference | 98.97% |
Analyst Consensus | Strong Buy |
Analyst Count | 13 |
Revenue Growth Forecast (5Y) | 59.00% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Legend Biotech has an Altman Z-Score of 8.85 and a Piotroski F-Score of 2.
Altman Z-Score | 8.85 |
Piotroski F-Score | 2 |